Experts said there should be comprehensive, cost-based price controls covering all oncology therapies, permanent statutory margin caps across distribution channels and full scrutiny of company assistance programmes. NPPA cuts anti-cancer drug prices; activists urge deeper affordability beyond margins, citing drastic MRPs and calls for broader reforms. India has capped trade margins at 30% on 137 non-scheduled anti-cancer drugs to reduce treatment costs. Experts call for standardised care, quality checks, cost-effective medicines and.